Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Canine Arthritis Treatment Market: By Treatment: Non-Steroidal Anti-Inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Others; By Route of Administration: Oral, Injectable; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Canine Arthritis Treatment Market Outlook

The global canine arthritis treatment market stood at a value of nearly USD 2 billion in 2020. The market is further expected to grow at a CAGR of 5% in the forecast period of 2022-2027.

 

Global Canine Arthritis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America Dominates the Canine Arthritis Treatment Industry Globally

North America is the leading canine arthritis treatment market globally and the region is expected to maintain its dominance in the forecast period as well. The growth can be attributed to the increased pet adoptions and the high expenditure on pet care in the region. Within North America, the United States significantly contributes to the industry growth. According to the American Pet Products Association, the US pet owners spent over USD 7.4 billion on vet care in 2017. This demonstrates high awareness regarding the health of pet among the general population in the region. Europe follows North America in terms of market value, with around USD 6.1 billion spending on vet care in the same year. Meanwhile, the Asia Pacific is expected to witness a relatively higher growth in the forecast period owing to the expanding pet care market in emerging nations like India. The growing awareness regarding canine arthritis treatment in such regions are expected to provide enhanced growth opportunities to the market in the coming years.

 

Canine Arthritis Treatment: Industry Definition and Segmentation

Canine arthritis is a medical condition in pets that results in inflammation in joints, thereby affecting knee, elbow, spinal cord, and other joints. Some of the causes of canine arthritis in dogs include accidental injuries, obesity, repetitive stress from athletic activities, and improper nutrition. The lack of treatment can lead to a substantial increase in inflammation and pain and decreased range of motion. However, early detection of problem and its proper management can help pets to remain active. The most common form of arthritis is osteoarthritis, which is commonly known as degenerative joint disease (DJD). Generally, osteoarthritis treatment is multimodal, that is, it involves the use of several different therapies simultaneously to achieve the best result. The treatment is typically focused on reducing pain, controlling inflammation, improving quality of life, and slowing the development of the disease.

 

Global Canine Arthritis Treatment Market By DIstribution Channel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By treatment, the market is divided into:

  • Non-Steroidal Anti-Inflammatory Medications (NSAIDs)
  • Opioids
  • Stem Cell Therapy
  • Others

The market is divided based on route of administration into:

  • Oral
  • Injectable

On the basis of distribution channel, the industry can be segmented into:

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies
  • Online
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Canine Arthritis Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Prevalence of Osteoarthritis in Dogs and the Growing Pet Care Market to Bolster the Growth of the Canine Arthritis Treatment Industry

The increasing incidences of arthritis in dogs, particularly osteoarthritis, is the major factor driving the growth of the canine arthritis treatment industry. Osteoarthritis affects as many as one in five dogs and is a common problem in older dogs and large breeds. The development of osteoarthritis in pets can be prevented through proper diet, exercise, and the use of protective joint supplements. The canine arthritis treatment industry is further supported by the growing pet care market, particularly in developing nations like India. Over the forecast period, increasing awareness regarding canine arthritis treatment is expected to further accelerate the market growth.

Due to the outbreak of the COVID-19 pandemic, nonessential vet visits have been restricted, however, there has been a spike in adoption of pets and foster applications in 2020. The shelters across the United States have reported a rise in foster applications as people prepare to spend more time at home amidst the lockdown. This is expected to aid the industry growth in the forecast period.

 

Key Industry Players in the Global Canine Arthritis Treatment Market

The report gives a detailed analysis of the following key players in the global canine arthritis treatment industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Boehringer Ingelheim (Canada) Ltd.
  • America Regent, Inc.
  • Elanco Animal Health Incorporated
  • Zoetis Services LLC
  • American Regent, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Treatment, Route of Administration, Distribution Channel, Region
Breakup by Treatment Non-Steroidal Anti-Inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Others
Breakup by Route of Administration Oral, Injectable
Breakup by Distribution Channel Veterinary Hospitals and Clinics, Retail Pharmacies, Online, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Boehringer Ingelheim (Canada) Ltd., America Regent, Inc., Elanco Animal Health Incorporated, Zoetis Services LLC, American Regent, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Canine Arthritis Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Canine Arthritis Treatment Historical Market (2017-2021) 
    8.3    Global Canine Arthritis Treatment Market Forecast (2022-2027)
    8.4    Global Canine Arthritis Treatment Market by Treatment
        8.4.1    Non-Steroidal Anti-Inflammatory Medications (NSAIDs)
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Opioids
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Stem Cell Therapy
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Others
    8.5    Global Canine Arthritis Treatment Market by Route of Administration
        8.5.1    Oral
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Injectable
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Canine Arthritis Treatment Market by Distribution Channel
        8.6.1    Veterinary Hospitals and Clinics
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Retail Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Online
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Others
    8.7    Global Canine Arthritis Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Boehringer Ingelheim (Canada) Ltd.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    America Regent, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Elanco Animal Health Incorporated
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Zoetis Services LLC
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    American Regent, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Canine Arthritis Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Canine Arthritis Treatment Historical Market: Breakup by Treatment (USD Billion), 2017-2021
3.    Global Canine Arthritis Treatment Market Forecast: Breakup by Treatment (USD Billion), 2022-2027
4.    Global Canine Arthritis Treatment Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
5.    Global Canine Arthritis Treatment Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
6.    Global Canine Arthritis Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
7.    Global Canine Arthritis Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
8.    Global Canine Arthritis Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Canine Arthritis Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Canine Arthritis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Canine Arthritis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Canine Arthritis Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global canine arthritis treatment market attained a value of nearly USD 2 billion.

The market is projected to grow at a CAGR of 5% between 2021 and 2026.

The major drivers of the market include rising population, rising urbanisation, and the increasing incidences of arthritis in dogs and growing pet care market.

Increased pet adoptions and growing awareness regarding canine arthritis treatment are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with the North America dominating the market shares.

The routes of admission include oral and injectable.

The treatment segments are non-steroidal anti-inflammatory medications (NSAIDs), opioids, and stem cell therapy, among others.

The diverse distribution channels for market are veterinary hospitals and clinics, retail pharmacies, and online, among others.

The major players in the industry are Boehringer Ingelheim (Canada) Ltd., America Regent, Inc., Elanco Animal Health Incorporated, Zoetis Services LLC and American Regent, Inc. among others.

Analyst Review

The global canine arthritis treatment market attained a value of USD 2 billion in 2020, driven by the rising pet care industry. Aided by the growing pet adoptions, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 5%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its routes of admission, the canine arthritis treatment industry can be segmented into oral and injectable. The classification based on treatment are non-steroidal anti-inflammatory medications (NSAIDs), opioids, and stem cell therapy, among others. On the basis of distribution channels, the industry is divided into veterinary hospitals and clinics, retail pharmacies, and online, among others. The major regional markets for canine arthritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with the North America accounting for the greatest share. The key players in the above market include Boehringer Ingelheim (Canada) Ltd., America Regent, Inc., Elanco Animal Health Incorporated, Zoetis Services LLC and American Regent, Inc. among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER